Canada Life Portfolio holdings
AUM
$63.1B
1-Year Return
22.24%
This Quarter Return
-2.08%
1 Year Return
+22.24%
3 Year Return
+92.16%
5 Year Return
+162.31%
10 Year Return
+335.82%
AUM
$56.8B
AUM Growth
-$1.22B
(-2.1%)
Cap. Flow
+$1.04B
Cap. Flow
% of AUM
1.83%
Top 10 Holdings %
Top 10 Hldgs %
26.8%
Holding
2,035
New
14
Increased
744
Reduced
991
Closed
40
Top Buys
| 1 |
Spotify
SPOT
|
+$87.9M |
| 2 |
Apple
AAPL
|
+$83.1M |
| 3 |
Microsoft
MSFT
|
+$62.5M |
| 4 |
Nike
NKE
|
+$55.4M |
| 5 |
NVIDIA
NVDA
|
+$38.3M |
Top Sells
| 1 |
AbbVie
ABBV
|
+$38.8M |
| 2 |
Exelon
EXC
|
+$24.6M |
| 3 |
NextEra Energy, Inc.
NEE
|
+$24.2M |
| 4 |
CRH
CRH
|
+$22.6M |
| 5 |
TSMC
TSM
|
+$22.1M |
Sector Composition
| 1 | Technology | 28.78% |
| 2 | Financials | 14.51% |
| 3 | Healthcare | 11.64% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Communication Services | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
TriplePoint Venture Growth BDC
TPVG
$267M
| $266K | ﹤0.01% |
38,025
+5,541
| +17% | +$38.8K |
|
1702
IDEAYA Biosciences
IDYA
$2.16B
| $259K | ﹤0.01% |
15,807
| – | – |
|
1703
Pennant Group
PNTG
$884M
| $256K | ﹤0.01% |
10,164
| – | – |
|
1704
Syndax Pharmaceuticals
SNDX
$1.34B
| $254K | ﹤0.01% |
20,662
| – | – |
|
|
XIFR
1705
XPLR Infrastructure, LP
XIFR
$947M
| $241K | ﹤0.01% |
25,252
| – | – |
|
1706
Geron
GERN
$810M
| $240K | ﹤0.01% |
150,298
+6,300
| +4% | +$10.1K |
|
1707
Marcus Corp
MCS
$504M
| $236K | ﹤0.01% |
14,107
+12,981
| +1,153% | +$217K |
|
1708
NovaGold Resources
NG
$2.82B
| $236K | ﹤0.01% |
82,156
| – | – |
|
1709
Xenon Pharmaceuticals
XENE
$2.79B
| $236K | ﹤0.01% |
7,024
-8,887
| -56% | -$299K |
|
1710
Usana Health Sciences
USNA
$557M
| $234K | ﹤0.01% |
8,690
-3,076
| -26% | -$82.8K |
|
1711
Towne Bank
TOWN
$2.83B
| $232K | ﹤0.01% |
6,748
| – | – |
|
1712
Equinox Gold
EQX
$8.29B
| $231K | ﹤0.01% |
33,651
| – | – |
|
1713
MiMedx Group
MDXG
$1.03B
| $228K | ﹤0.01% |
29,938
-11,095
| -27% | -$84.5K |
|
1714
Atkore
ATKR
$2.06B
| $225K | ﹤0.01% |
3,737
| – | – |
|
1715
Vermilion Energy
VET
$1.14B
| $218K | ﹤0.01% |
27,067
+5,145
| +23% | +$41.4K |
|
1716
Castle Biosciences
CSTL
$621M
| $215K | ﹤0.01% |
10,713
| – | – |
|
|
OLP
1717
One Liberty Properties
OLP
$494M
| $214K | ﹤0.01% |
8,147
+14
| +0.2% | +$368 |
|
1718
REV Group
REVG
$3.02B
| $211K | ﹤0.01% |
6,680
| – | – |
|
1719
Ranpak Holdings
PACK
$395M
| $206K | ﹤0.01% |
38,016
| – | – |
|
1720
Arcutis Biotherapeutics
ARQT
$2.07B
| $201K | ﹤0.01% |
+12,816
| New | +$201K |
|
1721
VSE Corp
VSEC
$3.4B
| $199K | ﹤0.01% |
1,653
| – | – |
|
1722
Iovance Biotherapeutics
IOVA
$821M
| $198K | ﹤0.01% |
59,463
+2,198
| +4% | +$7.32K |
|
|
SASR
1723
DELISTED
Sandy Spring Bancorp Inc
SASR
| $198K | ﹤0.01% |
7,035
+344
| +5% | +$9.68K |
|
1724
Baytex Energy
BTE
$1.83B
| $194K | ﹤0.01% |
87,987
| – | – |
|
1725
Conduent
CNDT
$445M
| $194K | ﹤0.01% |
71,468
| – | – |
|